Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000156127 | SCV000205841 | pathogenic | Primary dilated cardiomyopathy; Brugada syndrome | 2013-10-21 | criteria provided, single submitter | clinical testing | The Pro1332fs variant in SCN5A has not been previously reported in individuals w ith cardiomyopathy. This frameshift variant is predicted to alter the protein?s amino acid sequence beginning at position 1332 and lead to a premature terminati on codon 4 amino acids downstream. Heterozygous loss of function variants of the SCN5A gene have been previously reported for DCM (Olson 2005), Brugada syndrome (Kapplinger 2010), ventricular fibrillation (Chen 1998), and atrioventricular b lock and cardiac conduction defects (Baruteau 2012). Individuals with a frameshi ft or missense SCN5A variant and a diagnosis of DCM have been reported to presen t overlapping features with conduction defects, including atrial fibrillation an d arrhythmia (Olson 2005, McNair 2011). In summary, this variant meets our crite ria to be classified as pathogenic (http://pcpgm.partners.org/LMM). |
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV000845525 | SCV000987634 | pathogenic | Primary familial dilated cardiomyopathy | criteria provided, single submitter | clinical testing |